Maximum Strength Laxative Tablet, Coated
NDC Package 69842-195-24

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Maximum Strength Laxative (sennosides) tablets is sennosides are used to treat constipation. This formulation utilizes a tablet, coated delivery system. Marketed by Cvs Health, this product is identified by NDC 69842-195 and is authorized under FDA application M007.

Identification & Billing

NDC Package Code
69842-195-24
Package Description
24 TABLET, COATED in 1 BLISTER PACK
Product Code
69842-195
11-Digit Billing Format
69842019524
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Maximum Strength Laxative
Non-Proprietary Name
Sennosides
Substance Name
Sennosides
Dosage Form
Tablet, Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is covered with a designated coating.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
SENNOSIDES 25 mg/1
Usage Information
Sennosides are used to treat constipation. They may also be used to clean out the intestines before a bowel examination/surgery. Sennosides are known as stimulant laxatives. They work by keeping water in the intestines, which causes movement of the intestines.

Regulatory & Marketing

Labeler Name
Cvs Health
Product Type
Human Otc Drug
FDA Application #
M007
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
12-01-2020
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (69842-195). Click a package code to view its specific billing and regulatory data.

69842-195-09
90 TABLET, COATED in 1 BOTTLE, PLASTIC
69842-195-25
250 TABLET, COATED in 1 BOTTLE, PLASTIC

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69842-195-24 identifies a specific commercial package of 24 tablet, coated in 1 blister pack of Maximum Strength Laxative, a human over the counter drug labeled by Cvs Health. This tablet, coated is formulated for oral use and contains sennosides as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Cvs Health on December 01, 2020. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Sennosides are used to treat constipation. They may also be used to clean out the intestines before a bowel examination/surgery. Sennosides are known as stimulant laxatives. They work by keeping water in the intestines, which causes movement of the intestines.

How is this Cvs Health product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69842019524. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
69842-195-24
11-Digit CMS (5-4-2)
69842-0195-24

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.